AR073460A1 - Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo - Google Patents

Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo

Info

Publication number
AR073460A1
AR073460A1 ARP090102754A ARP090102754A AR073460A1 AR 073460 A1 AR073460 A1 AR 073460A1 AR P090102754 A ARP090102754 A AR P090102754A AR P090102754 A ARP090102754 A AR P090102754A AR 073460 A1 AR073460 A1 AR 073460A1
Authority
AR
Argentina
Prior art keywords
therapeutic agent
ophthalmic device
same
formation method
administration capacity
Prior art date
Application number
ARP090102754A
Other languages
English (en)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR073460A1 publication Critical patent/AR073460A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Reivindicacion 1: Un dispositivo oftálmico caracterizado porque comprende: una masa de material, la masa de material que incluye un material acrílico, el material acrílico que incluye una porcion sustancial de acrilato hidrofobico; y agente terapéutico asociado con la masa de material en donde el agente terapéutico es hidrofobico y tiene un CP Log P que es al menos 1.0; en donde la masa de material está configurada para la insercion en un ojo de un humano.
ARP090102754A 2008-07-21 2009-07-20 Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo AR073460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8235208P 2008-07-21 2008-07-21

Publications (1)

Publication Number Publication Date
AR073460A1 true AR073460A1 (es) 2010-11-10

Family

ID=41445879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102754A AR073460A1 (es) 2008-07-21 2009-07-20 Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo

Country Status (16)

Country Link
US (3) US9233069B2 (es)
EP (1) EP2303331B1 (es)
JP (3) JP5954888B2 (es)
KR (1) KR101663111B1 (es)
CN (1) CN102231989B (es)
AR (1) AR073460A1 (es)
AU (2) AU2009274209B2 (es)
BR (1) BRPI0917390A2 (es)
CA (1) CA2730264C (es)
ES (1) ES2909726T3 (es)
IL (1) IL210385A (es)
MX (1) MX340636B (es)
NZ (1) NZ590472A (es)
RU (1) RU2519704C2 (es)
TW (1) TWI531362B (es)
WO (1) WO2010011585A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008157372A2 (en) 2007-06-14 2008-12-24 Massachusetts Institute Of Technology Self assembled films for protein and drug delivery applications
US9198875B2 (en) * 2008-08-17 2015-12-01 Massachusetts Institute Of Technology Controlled delivery of bioactive agents from decomposable films
WO2011140136A2 (en) * 2010-05-03 2011-11-10 Massachusetts Institute Of Technology Drug delivery coating and devices
US8235053B2 (en) 2010-09-08 2012-08-07 Alcon Research, Ltd. Implantable punctal plug
US8864703B2 (en) 2010-10-05 2014-10-21 Alcon Research, Ltd. Drug introduction and placement system
EP2841056A4 (en) 2012-04-23 2015-09-16 Massachusetts Inst Technology COATED PARTICLES LAYER BY LAYER STABLE
JP6205364B2 (ja) * 2012-09-05 2017-09-27 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
WO2014134029A1 (en) 2013-02-26 2014-09-04 Massachusetts Institute Of Technology Nucleic acid particles, methods and use thereof
US9463244B2 (en) 2013-03-15 2016-10-11 Massachusetts Institute Of Technology Compositions and methods for nucleic acid delivery
CA2914146A1 (en) * 2013-06-03 2014-12-11 Oji Holdings Corporation Method for producing sheet containing fine fibers
US9949874B2 (en) * 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
FR3028410A1 (fr) 2014-11-18 2016-05-20 Pierre Coulon Implant capsulaire multifonctionnel
TWI606850B (zh) * 2015-12-22 2017-12-01 美樺興業股份有限公司 人工水晶體以及其製作方法
RU2612121C1 (ru) * 2016-01-27 2017-03-02 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт глазных болезней" Лечебная силикон-гидрогелевая мягкая контактная линза
EP3210572A1 (en) 2016-02-29 2017-08-30 Elodie Jane Siney Intraocular lens comprising drug-containing microspheres
US11419947B2 (en) 2017-10-30 2022-08-23 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
CN108578768B (zh) * 2018-03-23 2020-05-01 四川大学 一种高强度可注射的人工晶状体材料及其制备方法和应用
EP3801385A1 (en) * 2018-06-05 2021-04-14 Corneat Vision Ltd. A synthetic ophthalmic graft patch
US11806278B2 (en) * 2018-08-30 2023-11-07 Qura, Inc. Implantable intraocular drug delivery devices
CN115364280B (zh) * 2021-12-15 2023-08-18 郑州大学第一附属医院 一种药物缓释型人工晶状体及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240163A (en) 1979-01-31 1980-12-23 Galin Miles A Medicament coated intraocular lens
US5098443A (en) 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US6197059B1 (en) 1990-04-27 2001-03-06 Medevec Licensing, B.V. Accomodating intraocular lens
US5290892A (en) * 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5470932A (en) 1993-10-18 1995-11-28 Alcon Laboratories, Inc. Polymerizable yellow dyes and their use in opthalmic lenses
JP3206004B2 (ja) 1995-06-07 2001-09-04 アルコン ラボラトリーズ， インコーポレイテッド 改良された高屈折率の眼科用レンズ材料
US5554187A (en) 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
EP0879268A1 (en) 1996-02-09 1998-11-25 Surface Solutions Laboratories, Inc. Water-based hydrophilic coating compositions and articles prepared therefrom
PT935512E (pt) * 1996-11-01 2002-09-30 Alcon Lab Inc Metodo de polimero criogenico para artigos acrilicos moles
FR2757064B1 (fr) 1996-12-13 2000-02-04 Ioltechnologie Production Lentille intraoculaire contenant un medicament relargable
US5843186A (en) 1996-12-20 1998-12-01 Implemed, Inc. Intraocular lens with antimicrobial activity
US6353069B1 (en) 1998-04-15 2002-03-05 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials
US6106554A (en) 1999-02-25 2000-08-22 Bausch & Lomb Surgical, Inc. Intraocular lens implants for the prevention of secondary cataracts
CA2426765C (en) 2000-10-24 2012-06-05 Shunichi Shiozawa Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
CA2473355C (en) 2002-01-18 2012-01-03 Michael E. Snyder Sustained release ophthalmological device and method of making and using the same
US7153573B2 (en) * 2002-08-08 2006-12-26 Kao Corporation Polymer composite particle comprising metal oxide and silicone and/or fluorine and method of producing the same
GB0219024D0 (en) 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
US7273896B2 (en) 2003-04-10 2007-09-25 Angiotech Pharmaceuticals (Us), Inc. Compositions and methods of using a transient colorant
RU2251394C2 (ru) 2003-06-23 2005-05-10 Войсковая Часть 41598 Композиция и способ изготовления лечебной мягкой контактной линзы
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
US9839719B2 (en) * 2005-05-25 2017-12-12 Cis Pharma Ag Biocompatible polymers and co-polymers, and uses thereof
US20070218104A1 (en) * 2006-03-15 2007-09-20 Bausch & Lomb Incorporation Rate controlled release of a pharmaceutical agent in a biodegradable device
RU2450802C2 (ru) 2006-11-06 2012-05-20 Новартис Аг Офтальмологические устройства и способы их изготовления и применения

Also Published As

Publication number Publication date
CN102231989A (zh) 2011-11-02
US20170319474A1 (en) 2017-11-09
ES2909726T3 (es) 2022-05-10
US9750685B2 (en) 2017-09-05
TW201004611A (en) 2010-02-01
WO2010011585A3 (en) 2011-04-07
US9233069B2 (en) 2016-01-12
EP2303331A2 (en) 2011-04-06
JP5954888B2 (ja) 2016-07-20
AU2015213358A1 (en) 2015-09-03
US20160081921A1 (en) 2016-03-24
NZ590472A (en) 2012-11-30
CN102231989B (zh) 2013-08-21
JP2016130267A (ja) 2016-07-21
MX340636B (es) 2016-07-19
KR101663111B1 (ko) 2016-10-06
US20100016439A1 (en) 2010-01-21
CA2730264A1 (en) 2010-01-28
EP2303331B1 (en) 2022-01-26
JP2011528714A (ja) 2011-11-24
TWI531362B (zh) 2016-05-01
BRPI0917390A2 (pt) 2015-11-17
RU2011106329A (ru) 2012-08-27
JP2014196357A (ja) 2014-10-16
CA2730264C (en) 2016-08-16
IL210385A0 (en) 2011-03-31
RU2519704C2 (ru) 2014-06-20
US9962334B2 (en) 2018-05-08
IL210385A (en) 2015-11-30
AU2009274209B2 (en) 2015-05-14
MX2011000774A (es) 2011-02-23
WO2010011585A2 (en) 2010-01-28
AU2009274209A1 (en) 2010-01-28
KR20110033288A (ko) 2011-03-30

Similar Documents

Publication Publication Date Title
AR073460A1 (es) Dispositivo oftalmico con capacidad de administracion de agente terapeutico y metodo de formacion del mismo
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
CL2016001041A1 (es) Implante intraocular biodegradable que contiene una matriz de polimero biodegradable, polietilenglicol 3350 y una prostamida; uso del mismo en la reducción de la presion ocular en el ojo de un mamifero; aparato para administrar el implante intraocular biodegradable; y método para confeccionar un implante intraocular biodegradable.
UY32537A (es) Tapones lagrimales
MX2009005644A (es) Gel util para el suministro de farmacos oftalmicos.
CL2011000513A1 (es) Metodos para reducir o inhibir la angiogenesis en un sujeto que tiene una enfermedad o condicion ocular asociada con la angiogenesis que comprende la administracion de un antagonista de tetraspanina 12(tspan12) y/o un antagonista de norrina.
CL2012001103A1 (es) Método para reducir el nivel del polipéptido tau desacetilado en una célula, que comprende poner en contacto la célula con un agente que incrementa la actividad de un polipéptido que desacetila tau y/o un agente que disminuye la actividad de un polipéptido que acetila tau; y usos terapéuticos para tratar una tauopatía.
AR060306A1 (es) Terapia de combinacion de anticuerpos contra ctla4
UY31205A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
HK1050477A1 (en) Use of exendins and agonists thereof for the treatment of hypertriglyceridemia.
AR056254A1 (es) SISTEMAS DE ADMINISTRACION INTRAOCULAR DE UNA DROGA DE LIBERACION SOSTENIDA QUE CONTIENE RETINOIDES, UN POLíMERO BIODEGRADABLE Y LOS METODOS RELACIONADOS
WO2008060359A3 (en) Biodegradable ocular implants and methods for treating ocular conditions
CY1110133T1 (el) Θεραπευτικος παραγων υπερλιπαιμιας που περιλαμβανει πιταβαστατινες και εικοσαπενταενοϊκο οξυ
TW200605918A (en) Biodegradable intravitreal tyrosine kinase implants
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
WO2010068281A3 (en) Contact lens drug delivery device
TN2009000381A1 (en) C5 antigens and uses thereof
AR053544A1 (es) Un dispositivo oftalmico y metodos para su produccion
WO2014179568A3 (en) Two-layer ocular implant
EA201690967A1 (ru) Глазное устройство
CL2012001583A1 (es) Preparación oftálmica que comprende: a) povidona yodada, b) un agente refrescante y c) uno o más entre alcanfor, borneol, lubricante, emoliente, antiinflamatorio esteroidal y antinflamatorio no esteroidal; y su uso para el tratamiento y/o profilaxis de un trastorno ocular o una infección.
WO2005105037A3 (en) Use of a viscoelastic composition for treating increased intraocular pressure
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
EP4173615A3 (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases

Legal Events

Date Code Title Description
FB Suspension of granting procedure